Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a

T. Uher, D. Horakova, T. Kalincik, N. Bergsland, M. Tyblova, D. P. Ramasamy, Z. Seidl, M. Vaneckova, J. Krasensky, E. Havrdova, R. Zivadinov
  • European Journal of Neurology, April 2015, Wiley
  • DOI: 10.1111/ene.12716

Predictors of disease activity in CIS (multiple sclerosis) patients

The author haven't finished explaining this publicationThe author haven't finished explaining this publication
The following have contributed to this page: Dr Tomas Kalincik and Dr. Tomas TU Uher